Enrolling Clinical Trials

  1. Home
  2. Clinical Research
  3. Enrolling Clinical Trials

Clinical Trials

Below, are descriptions of clinical trials in which we are currently participating or have recently participated at Southeastern Retina Associates’ three East Tennessee main locations. More information on clinical trials is available at clinicaltrials.gov.

To ask about trials currently enrolling and the requirements to take part, patients or referring physicians may call any of research locations listed below.

Knoxville Based Clinical Trials

Clinical Site Location:
Tennessee Valley Eye Center
140 Capital Dr., Suite 2A
Knoxville, TN 37922

CT Main Number: 865-934-3866

  • Wet Macular Degeneration
    Study: DRCR “Protocol AO” (Treatment Naïve)
    Learn More

    Study: EyeBio/Merck “Super Tuscan”
    Learn More

    Diabetic Retinopathy
    Study: DRCR “Protocol AF” (Non-Proliferative DR: Mild to Moderately Severe)
    Learn More

    Study: DRCR “Protocol AFA” (Various levels of DR)
    Learn More

    Macular Telangiectasia Type 2
    Study: LMRI “NHOR”
    Learn More

    Diabetic Macular Edema
    Study: EyeBio “BAROLO”
    Learn More

    Branch Retinal Vein Occlusion
    Study: EyeBio/Merck "Super Tuscan"
    Learn More

    Geographic Atrophy
    Study: Astellas Pharma "Reveal"
    Learn More

  • Geographic Atrophy
    Study: Gyroscope "Oracle”

    Diabetic Macular Edema
    Study: EyeBio/Merck "BRUNELLO"

    Wet Macular Degeneration
    Study: Roche-Genentech “Burgundy”

Chattanooga Based Clinical Trials

1961 Northpoint Blvd
Suite 110
Hixson, TN 37343

CT Main Number: 423-756-1002

  • Diabetic Macular Edema
    Study: EyeBio/Merck "Barolo"
    Learn More

    Choroidal Melanoma
    Study: Aura Biosciences "AU-011-301"
    Learn More

    Geographic Atrophy
    Study: K8 for GA
    Learn More

  • Diabetic Retinopathy
    Study: Novo Nordisk A/C “FOCUS”

    Wet Macular Degeneration
    Study: AbbVie “Ascent”
    Study: Long-term Follow-UP Study of RGX-314

Tri Cities Based Clinical Trials

Clinical Site Location:
161 Technology Lane
Johnson City, TN 37604

CT Main Number: 423-578-4364

  • Wet Macular Degeneration
    Study: AbbVie “Ascent”
    Learn More

    Geographic Atrophy
    Study: Astellas Pharma "Reveal"
    Learn More

  • RegenxBio
    Study: Ascent – Gene Therapy for Wet AMD

    Ocular Therapeutix
    Study: SOL-R – Tyrosine Kinase inhibitor implant for Wet AMD

    Annexon
    Study: ARCHER II – C1q complement inhibitor for Advanced Dry AMD/Geographic Atrophy

    Eyebio
    Study: Barolo – Wnt agonist treatment for Diabetic Macular Edema

  • Wet Age-Related Macular Degeneration
    Study: 4D Molecular Therapeutics, Inc. "4D"

Bristol Based Clinical Trials

109 Gate City Hwy
Bristol, VA 24201

CT Main Number: 423-578-4364

  • Geographic Atrophy associated with Age-Related Macular Degeneration
    Study: SIENNA

  • Geographic Atrophy associated with Age-Related Macular Degeneration
    Study: K8 Inflammasome